Tackling the Elective Backlog: A Spotlight Report on the Implementation and Impact of Surgical Hubs and Diagnostic Centres – November 2023
This report examines decision-making at Surgical Hubs and Community Diagnostic Centres, how NHS England is tackling the elective backlog through innovative means, and the role of medical technology and patient involvement.
Deja Review update
– August 2023
Our original 2016 report called for a system-wide adoption of technologies and a focus on longer term strategy and solutions to end the postcode lottery of access to medical technologies in the NHS. However, barriers to the uptake of innovation still exist, particularly for small and medium sized enterprises. With the government prioritising innovation through its MedTech Strategy and the Sinker Innovation Review, the MTG is calling for three recommendations to ensure the NHS can fully harness its benefits.
NHS Backlog Briefing
– October 2022
The backlog of care in the NHS increased significantly during the pandemic, with the highest number of patients waiting for care since records began. Its impact on patients included worsening conditions and poorer outcomes, as well as increasing pressure on the waiting list and wider NHS services.
In this report case studies illustrate how medical technology can be used to help reduce long waits for care. Addressing the backlog, and ensuring patients receive timely care should not come at the expense of patient choice. The MTG is calling for the NHS to ensure that patients voices are heard, and they are given agency in decisions on their own care, particularly equitable access to technology to support their care.
MTG Manifesto: MedTech the Solution
– November 2021
On the 20th anniversary of the formation of the Medical Technology Group, we celebrate the achievements in medical technology over the past two decades, and the benefits it has brought by improving patients’ lives, making the NHS safer and more efficient, and helping people back to work. The report also makes recommendations on how medical technology can address the major issues facing the NHS today and in the near future.
Medical Technology Access Accelerator
– March 2021
The NHS has long wrestled with the challenge of creating a system that allows for the systematic uptake and spread of innovation. Over many years, a number of reports have been published that have given rise to new organisations and Departments charged with solving this problem. At present, however, the NHS has not found a way to pull through innovative products – meaning patients miss out. For innovators, the system remains difficult to navigate and uptake is at best patchy, and at worst non-existent.
In this report, we propose eleven elements of the Access Accelerator for a more efficient system of innovation uptake to take best advantage of proven medical technology.
Our NHS: A spotlight on the Innovation Landscape
– January 2020
How healthy is the current NHS innovation landscape? In our latest study, ‘Our NHS: A Spotlight on the Innovation Landscape’, we assess the current mechanisms for innovation and technology, and whether they foster an environment that delivers timely treatments to patients and takes full advantage of the health technology on offer. This includes an evaluation of the key innovation organisations, based on factors such as how they perform, interact and operate with one another.
We also look at which changes have taken place since our 2016 Déjà Review report, assessing whether the development of the AAR took the recommendations made in this report into account and avoided previous mistakes.
STPs and the use of technology
– November 2018
Regional Sustainability and Transformation Plans (STPs) set out plans for revolutionising local healthcare systems and delivering the NHS Five Year Forward View, published by NHS England in 2014. The original STP documents vary in length and detail but are designed to clarify the strategic objectives in each geographical area.
As some STPs begin to evolve into Sustainability and Transformation Partnerships and Integrated Care Systems in order to implement the plans, this report examines what the regional NHS organisations need to do to ensure that innovation is at the heart of the strategy and that patients can get access to the technology they need.
The North-South NHS divide: how where you are – not what you need – dictates your care
– August 2017
The NHS has long strived to deliver equity of access to patients regardless of their location across the UK. NICE was originally established to help ensure that patients could access innovative treatments regardless of where they live in the country. Following this, the Government established the 18 week referral to treatment waiting target to ensure that patients get access in a timely manner.
The Medical Technology Group (MTG) examined data from all 209 Clinical Commissioning Groups (CCGs) from across England to find out how effective they are at giving patients access to medical technology.
Déjà Review: What lessons can be learnt from the past?
– June 2016
Improving the way the NHS uses innovation has become the holy grail of NHS efficiency. In 2004, Derek Wanless described the NHS as a ‘late and slow adopter of innovation’ in his review, ‘Securing Good Health for the Whole Population’. Since that report many people would argue that the situation remains the same, despite a series of initiatives and reports promoting better use of innovation.
In this report The Medical Technology Group (MTG) considered what can be learnt from previous initiatives and suggested ways the Accelerated Access Review (AAR) can have most impact.